HOME > 신경신호전달 > 참고문헌  
1) Bird MM. Ultrastructural studies on neuromuscular contacts and the formation of junctions in the flight muscle of Antheraea polyphemus (Lep.) I. Normal adult development. Cell Tissue Res. 1975;159:245-266.

2) Re L, Di SB, Concettoni C, Giusti P. Computerized estimation of spontaneous and evoked acetylcholine release at the neuromuscular junction J Pharmacol Methods. 1989;22:233-242.

3) Franklin RJ, Cranq AJ, Blankemore WF. The role of astrocytes in the remyelination of glia-free areas of demyelination. Adv Neurol. 1993;59:125-133.

4) Kaladnar K, Sharma CP. Supported cell mimetic monolayers and their interaction with blood. Langmuir. 2004;20:11115-11122.

5) Behr J, Empson RM, Schmitz D, Gloveli T, Heinemann U. Electrophysiological properties of neurons in the rat subiculum in vitro. Exp Brain Res. 1993;96:304-318.

6) Berg HC. Membrane dipole potentials. Biophys J. 1968;8:1051-1053.

7) Mikula S, Niebar E. Correlated inhibitory and excitatory inputs to the coincidence detector: analytical solution. IEEE Trans Neural Netw. 2004;15:957-962.

8) Rousset M, Cens T, Vanmau N, Charnet P. Ca2+-dependent interaction of BAPTA with phospholipids. FEBS Lett. 2004;576:41-45.

9) Scanziani M, Salia PA, Vogt KE, Malenka RC, Nicoll RA. Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature. 1997;385:630-634.

10) Westerink BH, Boster FJ, Wirix E. Formation and metabolism of dopamine in nine areas of the rat brain: modifications by haloperidol. J Neurochem. 1984;42:1321-1327.

11) Issidorides MR, Havaki S, Arvanitis 이, Chrysanthou-Piterou M. Noradrenaline storage function of species-specific protein bodies, markers of monoamine neurons in human locus coeruleus demonstrated by dopamine-beta-hydroxylase immunogold localization. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:829-847.

12) Park E, Na M, Choi J, Kim S, Lee JR, Yoon J, Park D, Sheng M, Kim E. The Shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta PIX guanine nucleotide exchange factor for Rac1 and Cdc42. J Biol Chem. 2003;278:19220-19229.

13) Leung YM, Kang Y, Xia F, Sheu L, Gao X, Xie H, Tsushina RG, Gaisano HY. Open form syntaxin-1A is a more potent inhibitor than wild type syntaxin-1A of Kv2.1 channels. Biochem J. 2005;387:195-202

14) Millan MJ, Lejeune F, Gobert A. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J Psychopharmacol. 2000;14:114-138.

15) Wennogle LP, Conder L, Winter C, Braunwalder A, Vlattas S, Kramer R, Cioffi C, Hu SI. Stabilization of C5a receptor--G-protein interactions through ligand binding. J Cell Biochem. 1994;55:380-388.

16) Magidovich E, Yifrach O. Conserved gating hinge in ligand- and voltage-dependent K+ channels. Biochemistry. 2004;43:13242-13247.

17) Yi JY, Shin I, Arteaga CL. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem. 2005;280:10870-10876

18) Yabe T, Herbert JT, Takanohashi A, Schwartz JP. Treatment of cerebellar granule cell neurons with the neurotrophic factor pigment epithelium-derived factor in vitro enhances expression of other neurotrophic factors as well as cytokines and chemokines. J Neurosci Res. 2004;77:642-652.

19) Wiedlocha A, Sorensen V. Signaling, internalization, and intracellular activity of fibroblast growth factor. Curr Top Microbiol Immunol. 2004;286:45-79.

20) Lewerenz J, Letz J, Methner A. Activation of stimulatory heterotrimeric G proteins Increases glutathione and protects neuronal cells against oxidative stress. J Neurochem. 2003;87:522-531.

21) York JD, Hunter T. Signal transduction. Unexpected mediators of protein phosphorylation.Science. 2004;306(5704):2053-2055.

22) Aronoff DM, Canetti S, Serezani CM, Luo M, Peters-Golden M. Cutting Edge:Macrophage Inhibition by Cyclic AMP (cAMP): Differential Roles of Protein Kinase A and Exchange Protein Directly Activated by cAMP-1. J Immunol. 2005;174:595-595.

23) Wayman GA, Kaech S, Grant WF, Davare M, Impey S, Tokumitsu H, Nozaki N, Banker G, Soldelig TR. Regulation of axonal extension and growth cone motility by calmodulin-dependent protein kinase I. J Neurosci. 2004;24:3786-3794.

24) Pierson-Mullany LK, Lanqe CA. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol Cell Biol. 2004;24:10542-10557.

25) Hatori H, Zenkoh T, Kobayashi M, Ohtsu Y, Shiqematsu N, Setoi H, Hino M, Handa H. FR225659-binding proteins: identification as serine/threonine protein phosphatase PP1 and PP2A using high-performance affinity beads. J Antibiot (Tokyo). 2004;57:456-461.

26) Zayzafoon M, Fulzele K, Mcdonald JM. Calmodulin and calmodulin-dependent kinase II alpha regulate osteoblast differentiation by controlling c-fos expression. J Biol Chem. 2005;280:7049-7059.

27) Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci. 2007;28:166-172.

28) Hendrickx M, Leyns L. Non-conventional Frizzled ligands and Wnt receptors. Dev Growth Differ 2008;50:229-243.

29) Shimada S, Kitayama S, Walther D, Uhl G. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain Res Mol Brain Res. 1992;13:359-362.

30) Simsek M, Al-Sharbati M, Al-Adawi S, Lawatia K. VNTR polymorphism for the human dopamine transporter gene (DAT1). Hum Mol Genet. 1993;2:335.

31) Doucette-stamm LA, Blakely DJ, Tian J, Mockus S, Mao JI. Population genetic study of the human dopamine transporter gene (DAT1). Genet Epidemiol. 1995;12:303-308.

32) Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience. 1998;84:223-228.

33) Chong W, Lee LH, Lee K, Lee MH, Park JB, Ryu PD. Subtypes of alpha1- and alpha2-adrenoceptors mediating noradrenergic modulation of spontaneous inhibitory postsynaptic currents in the hypothalamic paraventricular nucleus. J Neuroendocrinol 2004;16:450-457. Erratum in: J Neuroendocrinol 2004;16:566-567.

34) Mersmann HJ. Evidence of classic beta 3-adrenergic receptors in porcine adipocytes. J Anim Sci. 1996;74:984-992.

35) Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD. Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther 1998;287:733-743.

36) Koob GF. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry. 1999;469:1167-1180. Review.

37) Shpakov AO, Korol’kov VI, Plesneva SA. Effect of C-terminal peptide of G-protein alfa(s)-subunit on regulation of adenylate cyclase and protein kinase A activities by biogenic amines and glucagon in mollusc and rat muscles. Ross Fiziol Zh Im I M Sechenova 2003;89:837-850

38) Dawson LA, Nguyen HQ. The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur J Pharmacol 1996;318:213-220.

39) Gelernter J, Kranzler H, Cubells JF Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet. 1997;10:243-246.

40) Semba K. Aminergic and cholinergic afferents to REM sleep induction regions of the pontine reticular formation in the rat. J Comparative Neurol 1993;330:543-556

41) Giacobini E. Cholinergic receptors in human brain: Effects of aging and alzheimer disease. J Neurosci Res 1990;27:548-560

42) Fodero LR, Small DH. Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development? Drug Develop Res 2002;56:369-379.

43) Naoyuki I, Hiroshi W. Histamine and prostanoid receptors on glial cells. Glia 1994;11:102-109

44) Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. International Union of Pharmacology; Classification of histamine receptors. Pharmacol Rev 1997;49:253-278.

45) Johnston GAR. Multiplicity of GABA receptors. Biochem and Methodol (eds. Olsen RW, Venter, JC.) Alan R. Liss, Inc. 1986;5:57-71

46) Cerrito F, Aloisi G, Arminio P, FaniniA D. New GABA-A receptor subtype coupled with Ca++/Cl- synporter modulates aminergic release from rat brain neuronterminals. J Neurosci Res 1998;51:15-22

47) Sivilotti L. Nistri A. GABA receptor mechanisms in the central nervous system. Prog Neurobiol 1991;36:35-92.

48) Leonard BE. Therapeutic applications of benzodiazepine receptor ligands in anxiety Human Psychopharmacology: Clinical and Experimental 1999;14:125-135

49) Aprison MH, Ruano EG, Robertson DH, Lipkowitz KB. Glycine and GABA receptors: Molecular mechanisms controlling chloride ion flux. J Neurosci Res 1996;43:372-381

50) Oliver MW, Kessler M, Larson J, Schottler F, Lynch G. Glycine site associated with the NMDA receptor modulates long-term potentiation. Synapse 1990;5:265-270

51) Kelly A, Stanley CA. Disorders of glutamate metabolism Mental Retardation and Developmental. Disabil Res Reviews 2001;7:287-295

52) Olney JW. Excitotoxicity and N-methyl-D-Aspartate receptors. Drug Develop Res 1989;17:299-319

53) Jeziorski M, White FJ, Wolf ME. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 1994;16:137-147

54) Olster DH, Blaustein JD. Immunocytochemical colocalization of progestin receptors and endorphin or enkephalin in the hypothalamus of female guinea pigs. J Neurobiol 1990;21:768-780

55) Young LJ. Oxytocin and vasopressin as candidate genes for psychiatric disorders: Lessons from animal models. A J Med Genet Part B: Neuropsychiatric Genetics. 2001;105:53-54

56) Litwin LC, Goldstein JM. Effects of neurotensin on midbrain dopamine neuronal activity. Drug Develop Res 1994;32:6-12

57) Satake H, Kawada T. Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors Curr Drug Targets 2006;7:963-974

58) Beal MF, Clevens RA, Mazurek MF. Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes. Synapse 1998;2:463-467